Prof. Roberto Ferrari, MD, PhD, FESC Bibliography - Top 10 in ...

Prof. Roberto Ferrari, MD, PhD, FESC
Bibliography (2012)
1. Coronary artery disease in 2012: Revising common beliefs in the management of stable CAD.
Ferrari R. Nat Rev Cardiol. 2013 Jan 8. doi: 10.1038/nrcardio.2012.184.
2. Histone Acetylation Regulates Intracellular pH.
McBrian MA, Behbahan IS, Ferrari R, Su T, Huang TW, Li K, Hong CS, Christofk HR, Vogelauer M,
Seligson DB, Kurdistani SK.Mol Cell. 2012 Nov 29. doi:pii: S1097-2765(12)00906-9.
10.1016/j.molcel.2012.10.025.
3. Mediator and SAGA Have Distinct Roles in Pol II Preinitiation Complex Assembly and
Function.
Chen XF, Lehmann L, Lin JJ, Vashisht A, Schmidt R, Ferrari R, Huang C, McKee R, Mosley A, Plath
K, Kurdistani SK, Wohlschlegel J, Carey M.Cell Rep. 2012 Nov 29;2(5):1061-7. doi:
10.1016/j.celrep.2012.10.019.
4. Transcription reinitiation by RNA polymerase III.
Dieci G, Bosio MC, Fermi B, Ferrari R. Biochim Biophys Acta. 2012 Nov 3. doi:pii: S1874-
9399(12)00180-0. 10.1016/j.bbagrm.2012.10.009.
5. Impact of a recent hospitalization on treatment and prognosis of ST-segment elevation
myocardial infarction.
Campo G, Napoli N, Serenelli C, Tebaldi M, Ferrari R. Int J Cardiol. 2012 Oct 18. doi:pii: S0167-
5273(12)01321-6. 10.1016/j.ijcard.2012.09.200.
6. Our time: a call to save preventable death from cardiovascular disease (heart disease and
stroke).
Smith SC Jr, Collins A, Ferrari R, Holmes DR Jr, Logstrup S, McGhie DV, Ralston J, Sacco RL, Stam
H, Taubert K, Wood DA, Zoghbi WA.J Am Coll Cardiol. 2012 Dec 4;60(22):2343-8. doi:
10.1016/j.jacc.2012.08.962. Epub 2012 Sep 18.
7. Our time: a call to save preventable death from cardiovascular disease (heart disease and
stroke).
Writing Committee:, Smith SC Jr, Collins A, Ferrari R, Holmes DR Jr, Logstrup S, McGhie DV,
Ralston J, Sacco RL, Stam H, Taubert K, Wood DA, Zoghbi WA.Eur Heart J. 2012 Dec;33(23):2910-
6. doi: 10.1093/eurheartj/ehs313. Epub 2012 Sep 17..
8. Our Time: A Call to Save Preventable Death From Cardiovascular Disease (Heart Disease
and Stroke).
Smith SC Jr, Collins A, Ferrari R, Holmes DR Jr, Logstrup S Cand Jur, McGhie DV, Ralston J, Sacco
RL, Stam H, Taubert K, Wood DA, Zoghbi WA.Circulation. 2012 Dec 4;126(23):2769-2775. Epub
2012 Sep 17.
9. Gender- and age-related differences in clinical presentation and management of outpatients
with stable coronary artery disease.
Ferrari R, Abergel H, Ford I, Fox KM, Greenlaw N, Steg PG, Hu D, Tendera M, Tardif JC; For the
CLARIFY Investigators. Int J Cardiol. 2012 Sep 15. doi:pii: S0167-5273(12)01027-3.
10.1016/j.ijcard.2012.08.013.

10. Occurrence and impact of chronic obstructive pulmonary disease in elderly patients with
stable heart failure.
Boschetto P, Fucili A, Stendardo M, Malagù M, Parrinello G, Casimirri E, Potena A, Ballerin L,
Fabbri LM, Ferrari R, Ceconi C. Respirology. 2013 Jan;18(1):125-30. doi: 10.1111/j.1440-
1843.2012.02264.x.
11. Women and men with stable coronary artery disease have similar clinical outcomes: insights
from the international prospective CLARIFY registry.
Steg PG, Greenlaw N, Tardif JC, Tendera M, Ford I, Kääb S, Abergel H, Fox KM, Ferrari R;
CLARIFY Registry Investigators.Eur Heart J. 2012 Nov;33(22):2831-40. doi:
10.1093/eurheartj/ehs289. Epub 2012 Aug 26.
12. Polycomb repressive complex 1 (PRC1) disassembles RNA polymerase II preinitiation
complexes.
Lehmann L, Ferrari R, Vashisht AA, Wohlschlegel JA, Kurdistani SK, Carey M.J Biol Chem. 2012
Oct 19;287(43):35784-94. doi: 10.1074/jbc.M112.397430. Epub 2012 Aug 21.
13. Scl represses cardiomyogenesis in prospective hemogenic endothelium and endocardium.
Van Handel B, Montel-Hagen A, Sasidharan R, Nakano H, Ferrari R, Boogerd CJ, Schredelseker J,
Wang Y, Hunter S, Org T, Zhou J, Li X, Pellegrini M, Chen JN, Orkin SH, Kurdistani SK, Evans SM,
Nakano A, Mikkola HK. Cell. 2012 Aug 3;150(3):590-605. doi:
14. Relations between professional medical associations and healthcare industry, concerning
scientific communication and continuing medical education: a policy statement from the
European Society of Cardiology.
ESC Board. Rev Port Cardiol. 2012 Jul-Aug;31(7-8):529-38. doi: 10.1016/j.repc.2012.06.007.
15. Pro-inflammatory genetic profile and familiarity of acute myocardial infarction.
Ianni M, Callegari S, Rizzo A, Pastori P, Moruzzi P, Corradi D, Porcellini E, Campo G, Ferrari R,
Ferrario MM, Bitonte S, Carbone I, Licastro F. Immun Ageing. 2012 Jun 24;9(1):14. doi:
10.1186/1742-4933-9-14.
16. The in vitro effects of verbascoside on human platelet aggregation.
Campo G, Marchesini J, Bristot L, Monti M, Gambetti S, Pavasini R, Pollina A, Ferrari R.J Thromb
Thrombolysis. 2012 Oct;34(3):318-25.
17. Cinaciguat, a soluble guanylate cyclase activator: results from the randomized, controlled,
phase IIb COMPOSE programme in acute heart failure syndromes.
Gheorghiade M, Greene SJ, Filippatos G, Erdmann E, Ferrari R, Levy PD, Maggioni A, Nowack C,
Mebazaa A; COMPOSE Investigators and Coordinators. Eur J Heart Fail. 2012 Sep;14(9):1056-66.
Epub 2012 Jun 19.
18. Thrombin generation assay: a new tool to predict and optimize clinical outcome in
cardiovascular patients?
Campo G, Pavasini R, Pollina A, Fileti L, Marchesini J, Tebaldi M, Ferrari R.Blood Coagul
Fibrinolysis. 2012 Dec;23(8):680-7. doi: 10.1097/MBC.0b013e328355111f.
19. The Notch pathway: a crossroad between the life and death of the endothelium.
Rizzo P, Miele L, Ferrari R. Eur Heart J. 2012 May 29.

20. Relations between professional medical associations and the healthcare industry, concerning
scientific communication and continuing medical education--a policy statement from the
European Society of Cardiology.
European Society of Cardiology. Acta Cardiol. 2012 Apr;67(2):265-71.
21. ESC-EURObservational Research Programme: the Atrial Fibrillation Ablation Pilot Study,
conducted by the European Heart Rhythm Association.
Arbelo E, Brugada J, Hindricks G, Maggioni A, Tavazzi L, Vardas P, Anselme F, Inama G, Jais P,
Kalarus Z, Kautzner J, Lewalter T, Mairesse G, Perez-Villacastin J, Riahi S, Taborsky M, Theodorakis
G, Trines S; Atrial Fibrillation Ablation Pilot Study Investigators. Europace. 2012 Aug;14(8):1094-
103. Epub 2012 May 24.
22. Heart rate and use of beta-blockers in stable outpatients with coronary artery disease.
Steg PG, Ferrari R, Ford I, Greenlaw N, Tardif JC, Tendera M, Abergel H, Fox KM; CLARIFY
Investigators.PLoS One. 2012;7(5):e36284. doi: 10.1371/journal.pone.0036284. Epub 2012 May 3.
23. Reorganization of the host epigenome by a viral oncogene.
Ferrari R, Su T, Li B, Bonora G, Oberai A, Chan Y, Sasidharan R, Berk AJ, Pellegrini M, Kurdistani
SK. Genome Res. 2012 Jul;22(7):1212-21. doi: 10.1101/gr.132308.111. Epub 2012 Apr 12.
24. Prasugrel versus tirofiban bolus with or without short post-bolus infusion with or without
concomitant prasugrel administration in patients with myocardial infarction undergoing
coronary stenting: the FABOLUS PRO (Facilitation through Aggrastat By drOpping or
shortening Infusion Line in patients with ST-segment elevation myocardial infarction compared
to or on top of PRasugrel given at loading dOse) trial.
Valgimigli M, Tebaldi M, Campo G, Gambetti S, Bristot L, Monti M, Parrinello G, Ferrari R;
FABOLUS PRO Investigators. JACC Cardiovasc Interv. 2012 Mar;5(3):268-77. doi:
10.1016/j.jcin.2012.01.006.
25.Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a
randomized multicenter trial.
Valgimigli M, Campo G, Monti M, Vranckx P, Percoco G, Tumscitz C, Castriota F, Colombo F,
Tebaldi M, Fucà G, Kubbajeh M, Cangiano E, Minarelli M, Scalone A, Cavazza C, Frangione A,
Borghesi M, Marchesini J, Parrinello G, Ferrari R; Prolonging Dual Antiplatelet Treatment After
Grading Stent-Induced Intimal Hyperplasia Study (PRODIGY) Investigators.Circulation. 2012 Apr
24;125(16):2015-26. doi: 10.1161/CIRCULATIONAHA.111.071589. Epub 2012 Mar 21.
26. Relations between professional medical associations and the health-care industry, concerning
scientific communication and continuing medical education: a Policy Statement from the
European Society of Cardiology.
ESC Board. Eur Heart J. 2012 Mar;33(5):666-74. doi: 10.1093/eurheartj/ehr480.
27. The story of the heartbeat, II.
Ferrari R. Eur Heart J. 2012 Jan;33(2):152-3.
28. [Perivalvular leak assessment and closure: role of real-time three-dimensional
transesophageal echocardiography].
Mele D, Agricola E, Dal Monte A, Ancona MB, Ferrari R. G Ital Cardiol (Rome). 2012 Jan;13(1):38-
46. doi: 10.1714/1015.11054. Review. Italian.

29. The story of the heartbeat, I: part I—heart rate: the rhythm of life.
Ferrari R.
Eur Heart J. 2012 Jan;33(1):4-5.
30. Does the site of bleeding matter? A stratified analysis on location of TIMI-graded bleedings
and their impact on 12-month outcome in patients with ST-segment elevation myocardial
infarction.
Vranckx P, Campo G, Anselmi M, Bolognese L, Colangelo S, Biondi-Zoccai G, Moreno R, Piva T,
Favero L, Prati F, Nazzaro M, Díaz Fernández JF, Ferrari R, Valgimigli M; Multicenter Evaluation of
Single High-Dose Bolus Tirofiban vs. Abciximab with Sirolimus-Eluting Stent or Bare Metal Stent in
Acute Myocardial Infarction Study.EuroIntervention. 2012 May 15;8(1):71-8. doi:
10.4244/EIJV8I1A12.
31. The Mediterranean diet, part II.
Ferrari R.
Eur Heart J. 2011 Dec;32(24):3060-2.
32. Pacing transmural scar tissue reduces left ventricle reverse remodeling after cardiac
resynchronization therapy.
Mele D, Agricola E, Monte AD, Galderisi M, D'Andrea A, Rigo F, Citro R, Chiodi E, Marchese G,
Valentina PD, Calabrese A, Ferrari R.
Int J Cardiol. 2012 Jan 4.
33. Sex-specific benefits of sirolimus-eluting stent on long-term outcomes in patients with STelevation
myocardial infarction undergoing primary percutaneous coronary intervention:
insights from the Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus
Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction
Study trial.
Ferrante G, Presbitero P, Corrada E, Campo G, Bolognese L, Vassanelli C, Colangelo S, De Cesare N,
E Rodriguez A, Bramucci E, Moreno R, Piva T, Sheiban I, Pasquetto G, Prati F, Nazzaro MS, Ferrari
R, Valgimigli M. Am Heart J. 2012 Jan;163(1):104-11. doi: 10.1016/j.ahj.2011.09.026.
34. Epigenetic analysis: ChIP-chip and ChIP-seq.
Pellegrini M, Ferrari R.
Methods Mol Biol. 2012;802:377-87. doi: 10.1007/978-1-61779-400-1_25.
35. ACE inhibition modulates endothelial apoptosis and renewal via endothelial progenitor cells
in patients with acute coronary syndromes.
Cangiano E, Marchesini J, Campo G, Francolini G, Fortini C, Carrà G, Miccoli M, Ceconi C, Tavazzi
L, Ferrari R.
Am J Cardiovasc Drugs. 2011 Jun 1;11(3):189-98. doi: 10.2165/11589400-000000000-00000.
Erratum in: Am J Cardiovasc Drugs. 2012 Apr 1;12(2):126.